Replies to post #26241 on Ariad Pharmaceuticals Inc fka ARIA

[jaybe]

Don't forget Rachel McMinn lowered to $27M in Dec...


"...looking for slow initial Iclusig launch...We model $27M in 2013 US Iclusig sales, well below the company's soft guidance of <$50M and consensus of $49M. Our analysis shows consensus implies Iclusig outperforms the Tasigna US launch by 25%+"